Linda Montanari Programme P1: Monitoring the Situation

Slides:

Advertisements

Similar presentations

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.

Advertisements

M. Fe Caces, Ph. D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC June 2003 Treatment.

1 TDI &Prevalence First results of pilotproject A.W.Ouwehand W.Kuijpers Lisbon: TDI meeting september 2006.

1International Network of Drug Dependence Treatment and Rehabilitation Resource Centres Treatnet: the UNODC project Associated ASI adaptations and links.

Martin Bush (A), Katerina Kontogeorgiou & Maria Pouloudi (GR), Etienne Maffli (CH), Ton Ouwehan & Wil Kuijpers (NL), Bela Studnickova (CZ) Coordination:

Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital.

University Mental Health Research Institute Greek REITOX Focal Point - UMHRI EMCDDA TDI Expert Meeting September 2004 Katerina Kontogeorgiou Maria.

M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.

Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.

TDI meeting Lisbon 23rd and 24th of June Stichting Informatievoorziening Zorg - Randhoeve Postbus GH Houten.

Treatment Demand Data: a breakdown by gender in some EU countries Linda Montanari, Colin Taylor, Lisbon, September 2004 Annual Expert Meeting on.

Status of progress of TDI indicator Notrbert Frost, Linda Montanari, EMCDDA, September 2004 Annual Expert Meeting on Treatment Demand Indicator.

Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.

REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.

Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.

HELP Survey II Opiates and Heroin 167 Polk Street, Suite 320 Watertown, New York

Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.

Addiction Treatment Outcomes Prof Michael Gossop National Addiction Centre Maudsley Hospital/Institute of Psychiatry.

Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.

Estimation of the Prevalence of Problem Drug Use in Lithuania Dr Gordon Hay Centre for Drug Misuse Research University of Glasgow, United Kingdom.

An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.

National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,

NATMS Overview Kevin Shelton Treatment Information Manager 2 June 2009.

Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,

Annual report 2010: the state of the drugs problem in Europe.

An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.

Erik Iversen, Norway Workshop at the annual TDI expert meeting EMCDDA, Lisbon 25 September 2006 Data Coverage Assessment The Bergen Clinics Foundation,

Revision of Problem Drug Use indicator Danica Klempová and Julián Vicente 42nd Reitox HFP meeting, 27 May 2010.

A Profile of Women in Treatment in California Data from the California Outcome Measurement System January – December 2006.

Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.

EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,

Drugs and Substances YDAP Giuseppe Furno May 2011.

„ Roma and Drugs in Figures – the Czech Republic“ Budapest, October 2004 Czech National Focal Point for Drugs and Drug Addiction Office of the Government.

Predicting trends in fatal drug overdoses in Ireland: does day of the week matter? Simone Walsh, Ena Lynn and Suzi Lyons.

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine.

Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.

By Fred Kigozi M.D WPA Zone 14 Representative/ President Uganda Psychiatric Association, Director Butabika Hospital or

Regular and intensive use of cannabis and related problems: Some results from literature and from the 2002 REITOX reports (CT P1) Roland Simon.

Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.

شناخت مراجعه کننده و چگونگی گرفتن شرح حال باروری سالم.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.

Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.

World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.

PSY 425 Week 2 Individual Drug Profile Paper To purchase this material click on below link

Drug addiction: Therapeutic problems in everyday clinical practice

World Tuberculosis Day 2014

INTRODUCTION The oral route of drugs administration is the most important method of administering drugs for systemic effects.

Accessing Cannabis Users – Survey on Good Practice Approaches

NEVER TOO LATE TO COMPLETE SCHOOL

Global Mechanisms for Reporting of Treatment Data

Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria Addictions Lisbon 2017, Paper Session 2 –

MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS

World Drug Report 2018.

First year assessment of the French « cannabis outpatients clinics »

Continuous treatment in Finland

Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.

World Tuberculosis Day 2016

World Tuberculosis Day 2014

Treatment Prevalence Project Draft Guidelines

EXECUTIVE OFFICE OF THE NATIONAL ANTI-DRUGS COUCIL

Registration of treatment demands for substance use disorders in Belgium : Why are some clients registered anonymously? Jérôme Antoine, Françoise Renard.

Family Networks Web Transition Planning

Women’s Treatment and Resources

Эмийн гаж нөлөөг бүртгэн мэдээлэх, ач холбогдол

Communication and publications

Skopje, 21 November 2017, General Population Survey results– launch

Presentation transcript:

Linda Montanari Programme P1: Monitoring the Situation 2 October 2002 Meeting CICAD, EMCDDA, ONDCP, SAMHSA, UNDCP Treatment Demand Indicator First Analysis with TDI Data Linda Montanari Programme P1: Monitoring the Situation 22/11/2018

Social Profile of Clients Mean Age Clients with Children Living Status (Where) Labour Status 22/11/2018

Mean Age of People Seeking Treatment 22/11/2018

Clients with children (All Clients) 22/11/2018 Ouptaient Centres:- N. cases = 91490

Living Status - Where 22/11/2018

Labour Status 22/11/2018

Drug Related Information Primary Drug Route of Administration Source of Referral Frequency of Use Age at First Use Secondary Drug 22/11/2018

Primary Drug (New Clients) 22/11/2018 Outpatient Centres N. 34252

Primary Drug by Country among new clients 22/11/2018

Route of Administration 22/11/2018 Opiates: n. 12223 new; 96256 All / Cocaine: n. 7256 new; 17180 all / Stimulants: n. 1684 new; 8278 all

Source of Referral by Treatment Centre (All Clients) 22/11/2018 N clients: 114558

Frequency of use of some drug among all clients 22/11/2018 Outpatient centres –N. cases Opiates (68653), Cocaine (15230), Stimulants (16632), Cannabis (18429)

Age at First Use of Opiates among all clients (%values) 22/11/2018 Outpatient Centres – N. Cases = 74036

Age at First Use of Some Drugs among all clients 22/11/2018 Outpatient centres – N. cases: Opiates (74036); Cocaine (20469); Stimulants (11767); Cannabis (21676)

Secondary Drug among all clients by country 22/11/2018 Information Source: TDI - Outpatient Centres - All Treatments n. 79257